Ad is loading...
VGTSX
Price
$19.37
Change
-$0.10 (-0.51%)
Updated
Nov 15 closing price
VTSNX
Price
$129.61
Change
-$0.62 (-0.48%)
Updated
Nov 15 closing price
Ad is loading...

VGTSX vs VTSNX

Header iconVGTSX vs VTSNX Comparison
Open Charts VGTSX vs VTSNXBanner chart's image
Vanguard Total Intl Stock Index I
Price$19.37
Change-$0.10 (-0.51%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$129.61
Change-$0.62 (-0.48%)
VolumeN/A
CapitalizationN/A
VGTSX vs VTSNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VGTSX vs. VTSNX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VGTSX is a Buy and VTSNX is a Buy.

FUNDAMENTALS
Fundamentals
VGTSX (442B) and VTSNX (442B) have equal amount of cash in the bank . VTSNX (3.29) and VGTSX (3.20) have matching dividends . VGTSX was incepted earlier than VTSNX: VGTSX (29 years) vs VTSNX (14 years). VGTSX (4.00) and VTSNX (4.00) have comparable annual turnover. VGTSX has a lower initial minimum investment than VTSNX: VGTSX (0) vs VTSNX (5000000). VTSNX (10.92) and VGTSX (10.84) have marching annual gain over last year. VTSNX (15.91) and VGTSX (15.72) have equivalent 5 years return.
VGTSXVTSNXVGTSX / VTSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence29 years14 years-
Gain YTD4.4394.53598%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets442B442B100%
Annual Yield % from dividends3.203.2997%
Returns for 1 year10.8410.9299%
Returns for 3 years-5.97-5.86102%
Returns for 5 years15.7215.9199%
Returns for 10 years29.4329.8199%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLSK14.030.05
+0.36%
CleanSpark
BSRR31.33-0.19
-0.60%
Sierra Bancorp
GEHC81.76-1.16
-1.40%
GE HealthCare Technologies
NXTC1.31-0.03
-2.24%
NextCure
RCKT13.98-0.84
-5.67%
Rocket Pharmaceuticals